Quality of life and neurological disability in children and young people with ataxia telangiectasia.

Ataxia-telangiectasia Movement disorder Neurological disorder Quality of life Resilience

Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 10 03 2022
revised: 31 05 2022
accepted: 17 07 2022
pubmed: 7 8 2022
medline: 15 9 2022
entrez: 6 8 2022
Statut: ppublish

Résumé

To explore neurological factors affecting quality of life (QoL) in children and young people with ataxia-telangiectasia (A-T), from both child and parent perspective. 24 children/young people with A-T (mean age 11.2 ± 3.5 years; 13 males) and 20 parents were recruited, and 58% were reassessed after an average interval of 3.4 years. Participants completed the PedsQL QoL assessment. Participants with A-T underwent structured neurological examination. QoL data from 20 healthy controls and their parents was used for comparison. Children/young people with A-T rated their QoL higher than parental ratings across time points, with no longitudinal change. Higher age of the child participant correlated with lower parental (r = -0.43, p = .008) but not child ratings of QoL (r = -0.16, p = .380). Child and parent QoL ratings from the A-T group were lower than respective ratings from controls (η Neurological disability does not determine child/young person QoL ratings in A-T. While certain aspects of neurological disability predict parent-proxy ratings, there is no decline in QoL over time. These results may reflect resilience in the face of a complex life-limiting disorder.

Identifiants

pubmed: 35932633
pii: S1090-3798(22)00115-5
doi: 10.1016/j.ejpn.2022.07.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-39

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have stated that they had no interests which might be perceived as posing a conflict or bias.

Auteurs

Hannah L McGlashan (HL)

School of Psychology, University of Queensland, Brisbane, Australia; Surgical Treatment and Rehabilitation Service, Brisbane, Australia; Radiological Sciences, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Electronic address: h.mcglashan@uq.net.au.

Caroline V Blanchard (CV)

Radiological Sciences, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom.

Celia Luscombe (C)

c/o the A-T Society, Harpenden, United Kingdom.

Manish Prasad (M)

Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

Gabriel Chow (G)

Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

Dorothee P Auer (DP)

Radiological Sciences, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.

William P Whitehouse (WP)

Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Division of Child Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Rob A Dineen (RA)

Radiological Sciences, Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom; NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH